Dr. Alosco completed his undergraduate studies at Providence College and he earned his doctoral degree in clinical psychology, with a focus in neuropsychology from Kent State University in 2015. He completed his clinical internship in neuropsychology at the VA Boston Healthcare System. In 2015, Dr. Alosco was awarded a post-doctoral fellowship at the Boston University Chobanian & Avedisian School of Medicine through the NIA-funded Alzheimer’s Disease Training Program. In 2016, Dr. Alosco transitioned to a National Research Service Award from the NIH.

Dr. Alosco leads several NIH-funded human subject studies devoted to biomarker development for CTE and the long-term effects of repetitive head impacts on the white matter and vasculature. Dr. Alosco has published extensively in the fields of Alzheimer’s disease and related dementias, including CTE, and he is the PI of multiple NIH-funded grants. His research has set the stage for biomarker discovery in CTE and the long-term effects of repetitive head impacts on the white matter, and he has made major contributions to plasma biomarker development and validation in Alzheimer’s disease. He has written numerous book chapters, and he is the co-Editor of the Oxford Handbook of Adult Cognitive Disorders which was published by Oxford University Press in 2019.